TABLE 5.
Assessment of patients' depression
| Severity of depression | p value | ||
|---|---|---|---|
|
Minimal to mild n = 66 (78%) |
Moderate to severe n = 19 (22%) |
||
| Gender, n (%) | .3 | ||
| Female | 29 (43) | 10 (53) | |
| Male | 37 (56) | 9 (47) | |
| PD modality, n (%) | |||
| CAPD | 29 (44) | 4 (21) | .06 |
| RM‐APD | 28 (42) | 10 (53) | .3 |
| APD | 9 (14) | 5 (26) | .2 |
| Dyspnoea, n (%) | |||
| Yes | 20 (30) | 11 (58) | .03 |
| Difficult in BP control, n (%) | |||
| Yes | 20 (32) | 7 (37) | .5 |
| Reducing salt consumption | |||
| Increasing the dose of drug | |||
| Add new antihypertensive drug | |||
| Gain weight, n (%) | |||
| Yes | 27 (41) | 10 (53) | .3 |
| 1–3 kg | 22 (33) | 6 (32) | .6 |
| 3–5 kg | 5 (8) | 2 (11) | .5 |
| More than 5 kg | 0 | 2 (11) | .008 |
| Fatigue (frequently), n (%) | 28 (42) | 14 (74) | .01 |
| Palpitation (frequently), n (%) | 3 (5) | 6 (32) | .003 |
| Loss of appetite (frequently), n (%) | 10 (15) | 4 (21) | .4 |
| Bone‐muscle pain (frequently), n (%) | 16 (24) | 7 (37) | .2 |
| Constipation (frequently), n (%) | 7 (11) | 4 (21) | .2 |
| Peritonitis, n (%) | 2 (3) | 2 (11) | .2 |
| Did COVID‐19 effected your life, n (%) | |||
| Yes | 25 (38) | 7 (37) | .9 |
| Severity of anxiety, n (%) | .03 | ||
| Low | 64 (97) | 16 (84) | |
| Moderate | 2 (3) | 3 (16) | |
| Concerning level | 0 | 0 | |
Abbreviations: APD, automatized peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; PD, peritoneal dialysis; COVID‐19, novel coronavirus disease; RM‐APD, remote monitoring automatized peritoneal dialysis.